Literature DB >> 12167481

Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells.

Maria L Trincavelli1, Barbara Costa, Daniela Tuscano, Antonio Lucacchini, Claudia Martini.   

Abstract

The purpose of this study was to examine the regulation of A(2A) adenosine receptor (A(2A) AR) gene expression induced by proinflammatory cytokines in PC12 cells. The A(2A) AR mRNA levels were substantially increased following 3-48 hr PC12 cell treatment with interleukin 1 beta (500 unit/mL) or tumor necrosis factor alpha (1000 unit/mL), as revealed by RT-PCR analysis. In parallel, cell cytokine treatment induced an up-regulation of A(2A) receptor protein. Equilibrium radioligand binding studies on treated-cells showed a significant increase in maximum density of [3H] 2-(carboxyethylphenylethylamino) adenosine-5'-carboxamide binding sites, with no significant changes in the affinity constant value. The increase in A(2A) receptor density was also demonstrated by Western blot analysis. Interleukin 1 beta and tumor necrosis factor alpha effects on A(2A) AR mRNA and protein levels were detectable after 3 hr cytokine treatment and reached a maximum within 24 and 48 hr, respectively. These results demonstrated the existence of heterologous regulation of A(2A) ARs by proinflammatory cytokines. The biological significance of this regulation might be associated with modulating cellular activity in response to tissue damage associated with inflammatory mediator production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167481     DOI: 10.1016/s0006-2952(02)01222-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane.

Authors:  Nguyen D Khoa; Michael Postow; Jennifer Danielsson; Bruce N Cronstein
Journal:  Mol Pharmacol       Date:  2005-12-29       Impact factor: 4.436

Review 2.  Cytokine-purine interactions in behavioral depression in rats.

Authors:  Thomas R Minor; Qingjun Huang; Elizabeth A Foley
Journal:  Integr Physiol Behav Sci       Date:  2003 Jul-Sep

3.  Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis.

Authors:  Gabriela E Garcia; Luan D Truong; Ping Li; Ping Zhang; Jie Du; Jiang-Fan Chen; Lili Feng
Journal:  FASEB J       Date:  2007-09-26       Impact factor: 5.191

4.  Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors.

Authors:  Peter J Clark; Parsa R Ghasem; Agnieszka Mika; Heidi E Day; Jonathan J Herrera; Benjamin N Greenwood; Monika Fleshner
Journal:  Behav Brain Res       Date:  2014-07-11       Impact factor: 3.332

5.  Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy.

Authors:  Jun Huang; Ming-Na Chen; Juan Du; Hao Liu; Yu-Jiao He; Guo-Liang Li; Shu-Yu Li; Wei-Ping Liu; Xiao-Yan Long
Journal:  Neurochem Res       Date:  2016-04-02       Impact factor: 3.996

6.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

7.  Anti-inflammatory preconditioning by agonists of adenosine A1 receptor.

Authors:  Sigal Nakav; Cidio Chaimovitz; Yuval Sufaro; Eli C Lewis; Gad Shaked; David Czeiger; Moshe Zlotnik; Amos Douvdevani
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

8.  Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation.

Authors:  Mark D Smith; Dhaval P Bhatt; Jonathan D Geiger; Thad A Rosenberger
Journal:  J Neuroinflammation       Date:  2014-06-04       Impact factor: 8.322

9.  Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.

Authors:  Ying Liu; Marwan Alahiri; Bianca Ulloa; Boxun Xie; Saud A Sadiq
Journal:  Immun Inflamm Dis       Date:  2017-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.